Prof. Erik De Clercq, Prof. Jan Balzarini, Prof. Johan Neyts, Dr. Robert Snoeck, Dr. Lieve Naesens, Dr. Graciela Andrei

Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium
Antiviral screening.

Petr Jansa PhD, Tomáš Cihlář PhD, Gabriel Birkuš PhD, Richard Mackman PhD

Gilead Sciences, Inc., Foster City, California, U.S.A.
Biological activity screening, pharmacokinetic profiles of active compounds and mutual general cooperation within Gilead Sciences & IOCB Research Centre.

Dr. Luke Guddat

The School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, 4072 QLD, Australia
Antimalarial program.

Dr. Helena Mertlíková-Kaiserová

IOCB Prague
Cytostatic activity, inhibitory activity towards thymidine phosphorylase.

Dr. Zdeněk Zídek

Institute of Experimental Medicine, Academy of Sciences of the Czech Republic
Immunomodulatory activity.

Prof. Miroslav Strnad

Laboratory of Growth Regulators, Palacký University & Institute of Experimental Botany Academy of Sciences of the Czech Republic
Kinase Inhibitors.

František Stejskal PhD

Department of Infectious and Tropical Diseases, First Faculty of Medicine, Charles University in Prague, Czech Republic
Inhibitors of Toxoplasma gondii S-adenosyl-L-homocysteine hydrolase.

Dr. Petr Kodym

National Reference Laboratory for Toxoplasmosis, Prague, Czech Republic
Inhibitors of Toxoplasma gondii S-adenosyl-L-homocysteine hydrolase.

Martin Dračínský PhD

IOCB Prague
NMR spectroscopy.